1034827-56-9 Usage
Uses
Used in Pharmaceutical Synthesis:
4-Bromo-2-(trifluoromethyl)pyrimidine is utilized as a key intermediate in the synthesis of pharmaceuticals for its ability to contribute to the development of novel drug molecules. Its unique structural features allow for the creation of compounds with specific therapeutic properties, enhancing the range of treatments available for various medical conditions.
Used in Agrochemical Production:
In the agrochemical industry, 4-Bromo-2-(trifluoromethyl)pyrimidine serves as a crucial component in the formulation of new agrochemicals. Its incorporation into these products can lead to the development of more effective pesticides, herbicides, and other agricultural chemicals that are designed to improve crop yields and protect plants from pests and diseases.
Used in Specialty Chemicals:
4-Bromo-2-(trifluoromethyl)pyrimidine is also employed in the production of specialty chemicals, where its distinctive chemical properties can be leveraged to create compounds with unique applications in various industrial processes. Its versatility in organic synthesis makes it a valuable asset in the development of innovative chemical products.
Overall, 4-Bromo-2-(trifluoromethyl)pyrimidine is a versatile chemical compound with a wide range of applications across different industries, primarily due to its role in the synthesis of new and improved products in pharmaceuticals, agrochemicals, and specialty chemicals.
Check Digit Verification of cas no
The CAS Registry Mumber 1034827-56-9 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,0,3,4,8,2 and 7 respectively; the second part has 2 digits, 5 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 1034827-56:
(9*1)+(8*0)+(7*3)+(6*4)+(5*8)+(4*2)+(3*7)+(2*5)+(1*6)=139
139 % 10 = 9
So 1034827-56-9 is a valid CAS Registry Number.
1034827-56-9Relevant academic research and scientific papers
ANTIDIABETIC SPIROCHROMAN COMPOUNDS
-
Page/Page column 121, (2018/07/29)
Novel compounds of the structural formula (I), and the pharmaceutically acceptable salts thereof, are agonists of G-protein coupled receptor 40 (GPR40) and may be useful in the treatment, prevention and suppression of diseases mediated by the G-protein-coupled receptor 40. The compounds of the present invention may be useful in the treatment of Type 2 diabetes mellitus, and of conditions that are often associated with this disease, including obesity and lipid disorders, such as mixed or diabetic dyslipidemia, hyperlipidemia, hypercholesterolemia, and hypertriglyceridemia.
ACYL BIPIPERIDINYL COMPOUNDS, COMPOSITIONS CONTAINING SUCH COMPOUNDS AND METHODS OF TREATMENT
-
Page/Page column 42, (2008/12/06)
Bipiperidyl compounds of the formula: (I) are disclosed as useful for treating or preventing type 2 diabetes and similar conditions. Pharmaceutically acceptable salts and solvates are included as well. The compounds are useful as agonists of the g-protein coupled receptor GPR-119.
BIPIPERIDINYL COMPOUNDS, COMPOSITIONS CONTAINING SUCH COMPOUNDS AND METHODS OF TREATMENT
-
Page/Page column 38-39, (2008/12/07)
Bipiperidinyl compounds of the formula I, are disclosed as useful for treating or preventing type 2 diabetes and similar conditions. Pharmaceutically acceptable salts and solvates are included as well. The compounds are useful as agonists of the g-protein coupled receptor GPR-119.
